Merit Medical Systems Files 8-K

Ticker: MMSI · Form: 8-K · Filed: Nov 13, 2025 · CIK: 856982

Merit Medical Systems Inc 8-K Filing Summary
FieldDetail
CompanyMerit Medical Systems Inc (MMSI)
Form Type8-K
Filed DateNov 13, 2025
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, financials

Related Tickers: MMSI

TL;DR

MERIT MEDICAL SYSTEMS (MMSI) filed an 8-K on Nov 13, 2025, with financial updates.

AI Summary

Merit Medical Systems, Inc. filed an 8-K on November 13, 2025, reporting under Regulation FD and including financial statements and exhibits. The filing details the company's principal executive offices located at 1600 West Merit Parkway, South Jordan, Utah, 84095.

Why It Matters

This 8-K filing provides an update on Merit Medical Systems, Inc.'s corporate reporting and financial disclosures, which is important for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.

Key Players & Entities

  • MERIT MEDICAL SYSTEMS INC (company) — Registrant
  • 0000856982-25-000060 (document_id) — Accession Number
  • November 13, 2025 (date) — Report Date
  • 1600 West Merit Parkway (address) — Principal Executive Offices
  • South Jordan, Utah 84095 (location) — Principal Executive Offices Location

FAQ

What is the purpose of this 8-K filing?

This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting under Regulation FD and including financial statements and exhibits.

When was this 8-K filed?

The filing was made on November 13, 2025.

What is the official name of the company filing this report?

The official name of the registrant is Merit Medical Systems, Inc.

Where are Merit Medical Systems, Inc.'s principal executive offices located?

The principal executive offices are located at 1600 West Merit Parkway, South Jordan, Utah 84095.

What is the Commission File Number for Merit Medical Systems, Inc.?

The Commission File Number for Merit Medical Systems, Inc. is 000-18592.

Filing Stats: 547 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-11-13 17:14:59

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On November 13, 2025, Merit Medical Systems, Inc. ("Merit") issued a press release announcing certain updates with respect to its WRAPSODY Cell-Impermeable Endoprosthesis product. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. The information contained in Item 7.01 of this Current Report on Form 8-K (including the exhibits attached hereto) is furnished pursuant to General Instruction B.2 of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by Merit under the Securities Act of 1933, as amended, or the Exchange Act.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT NUMBER DESCRIPTION 99.1 Press Release, dated November 13, 2025, entitled "Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY Cell-Impermeable Endoprosthesis". 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MERIT MEDICAL SYSTEMS, INC. Date: November 13, 2025 By: /s/ Brian G. Lloyd Brian G. Lloyd Chief Legal Officer and Corporate Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.